2023 Publications Highlights

Promise Proteomics products in the literature!

Many of our customers and collaborators have used our Stable Isotope Labelled (SIL) proteins and monoclonal antibodies (mAbs) in their research work.

The topics range from oncology and neurology to cardiology!

We share a selection of 2023 published papers with our SIL proteins and SIL mAbs:

Development of a candidate reference measurement procedure by ID-LC-MS/MS for total tau protein measurement in cerebrospinal fluid (CSF) Clinical Chemistry and Laboratory Medicine, 61(7), 1235‑1244

IP-LC-MSMS Enables Identification of Three Tau O-GlcNAcylation Sites as O-GlcNAcase Inhibition Pharmacodynamic Readout in Transgenic Mice Overexpressing Human Tau Journal of Proteome Research, 22(4), 1309‑1321

Apolipoprotein E O-glycosylation is associated with amyloid plaques and APOE genotype Analytical Biochemistry, 672, 115156

Absolute quantification of synuclein proteoforms in plasma in patients with Synucleinopathies by LC-MRM mass spectrometry medRxiv (Cold Spring Harbor Laboratory)

Orally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low Density Lipoprotein Receptor Circulation, 148(2), 144‑158

Optimization of a Quantitative Anti-Drug Antibodies against Infliximab Assay with the Liquid Chromatography-Tandem Mass Spectrometry: A Method Validation Study and Future Perspectives Pharmaceutics, 15(5), 1477

Development of an ID-LC–MS/MS method using targeted proteomics for quantifying cardiac troponin I in human serum Clinical Proteomics, 20(1)

Global Discovery and Temporal Changes of Human Albumin Modifications by Pan-Protein Adductomics: Initial Application to Air Pollution Exposure Journal of the American Society for Mass Spectrometry, 34(4), 595‑607

7, parvis Louis Néel • BHT 52 A • CS 20050

38040 Grenoble Cedex 9 • FRANCE

PHONE: +33 4 38 02 36 50

contact@promise-proteomics.com

Home